Inside the research

Azenta, Inc.

AZTA Research profile · latest available data

Price overview

$34.02

▼ -0.18 (-0.5%)

52w hi$41.01
52w lo$16.02
Vol781.10K
As of25 Sep 2026

The Verdict

Hold

Our score +0.09

Short+0.26
Medium+0.16
Long-0.40

computed 2026-09-27

Key fundamentals

Azenta, Inc.

Healthcare · Medical Instruments & Supplies

Market cap$1.49B
Enterprise value$1.22B
Forward P/E57.91x
EV / EBITDA36.92x
P / S (ttm)2.43x
Profit margin-20.0%
Return on equity-7.0%
Revenue growth+12.0%
Debt / equity3.57

Layer Breakdown

LayerRawContribution
Fundamental-0.06
Sector+0.08
Technical+0.16
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

United States · www.azenta.com

Risk Metrics

Beta vs SPX1.35
Corr SPX0.38
Annual vol57.2%
Annual ret-1.6%
Sharpe-0.03
Max DD-70.7%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-08-11Officer / Director Change, Exhibitsread
2026-08-04Earnings Release, Exhibitsread
2026-07-08Material Agreement, Acquisition / Disposition…read
2026-05-05Earnings Release, Exhibitsread
2026-04-07Officer / Director Change, Reg FD Disclosure…read
2026-04-02Other Material Eventread
2026-03-04Material Agreement, Reg FD Disclosure…read
2026-02-04Earnings Release, Exhibitsread
2026-02-02Officer / Director Changeread
2026-01-29Shareholder Voteread
2025-12-29Material Agreement, Reg FD Disclosure…read
2025-12-10Reg FD Disclosure, Other Material Event…read

Insider Trades

DateInsiderRoleActionSharesValue
2026-05-15Starr EphraimOfficer, SVP, Gen CounselWithheld for tax3.62K$58.01K
2026-04-28MARTIN WILLIAM E. IIIOfficer, President MultioGrant17.79K$431.23K

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders7
Top-5 share99.8%
HHI3,614 (concentrated)

Top Holders

HolderValueShares
State Street Corp$47.47M1.86M
Citadel Advisors$18.54M726.50K
Capital Research / Capital World$9.83M385.17K
AQR Capital Management$7.31M292.88K
Millennium Management$4.17M163.36K
Fidelity / FMR LLC$131.50K5.15K
T. Rowe Price Group$1.75K68.49K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-08-118-Kview
2026-08-114view
2026-08-0610-Qview
2026-08-044view
2026-08-048-Kview
2026-07-088-Kview
2026-05-194view
2026-05-184view
2026-05-124view
2026-05-0810-Qview
2026-05-058-Kview
2026-04-304view
2026-04-163view
2026-04-078-Kview
2026-04-028-Kview

The Long Run

FY 2011–2025 · 15 years

LineLatestCAGRTrend
Revenue$593.82M-1.0%
Gross profit$198.01M+1.3%
Operating income-$8.70M-5.6%
Net income-$164.90M+36.4%
Cash from ops$22.30M-4.3%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$34.36$34.39$33.67$34.02781.10K
Sep 24$33.69$34.82$33.51$34.20917.80K
Sep 23$34.15$34.88$33.88$34.09769.30K
Sep 22$34.00$34.86$33.72$34.281.13M
Sep 21$33.53$33.97$33.10$33.75718.20K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →